BREAKING: Melanoma Adjuvant Therapy Faces Reimbursement Concerns The lack of definitive overall survival data for adjuvant therapy in stage III melanoma is prompting worries about reimbursement and treatment… The post Melanoma Adjuvant Therapy: OS Data Gaps Explained appeared first on NewsyList. Source link
BOSTON — Key DNA and chromosomal and immune cell changes in early-stage lung adenocarcinoma show significant associations with outcomes, representing potentially important early predictors to guide management of the increasingly prevalent, deadly disease, according to the results of a new study. “We found that DNA ploidy and chromosomal structure predict early recurrence in lung adenocarcinoma, … Read more
A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer has concluded. Led by Singapore clinician-scientists, the ASCOLT (Aspirin after completion of standard adjuvant therapy for colorectal cancer) trial is the first phase 3 study to assess the efficacy and safety of aspirin in preventing the recurrence of … Read more
“`html Aspirin’s Evolving Role in Colorectal Cancer Prevention: New Hope for Targeted Treatment Published: 2025-03-17 | World-Today-News.com Recent studies, including the ASCOLT and ALASCCA trials, are reshaping our understanding of aspirin’s potential in preventing colorectal cancer recurrence. while aspirin doesn’t offer a global benefit, research suggests it could be a powerful tool for specific patient … Read more
The treatment landscape for melanoma saw significant advancements in 2024, as highlighted by Elisa Funck-Brentano, MD, PhD, from Ambroise-Paré Hospital in Paris, France, during her presentation at the 2024 Dermatology Days of Paris conference in Paris. Checkpoint Inhibitors in Neoadjuvant Therapy The standard approach for treating resectable stage III melanoma with locoregional metastases has traditionally … Read more